Intraoperative Radiation Therapy Market - Global Forecasts to 2025

Table of Content

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY USED FOR THE STUDY 22
1.5 STAKEHOLDERS 22
1.6 SUMMARY OF CHANGES 22

2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
FIGURE 1 RESEARCH DESIGN 23
2.1.1 SECONDARY DATA 23
2.1.1.1 Secondary sources 25
2.1.2 PRIMARY DATA 25
2.1.2.1 Breakdown of primaries 26
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: INTRAOPERATIVE RADIATION THERAPY MARKET 26
2.2 MARKET ESTIMATION METHODOLOGY 26
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 27
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 27
2.2.2 END USER-BASED MARKET ESTIMATION 28
FIGURE 4 MARKET SIZE ESTIMATION: INTRAOPERATIVE RADIATION THERAPY MARKET 28
2.2.3 PRIMARY RESEARCH VALIDATION 29
2.3 DATA TRIANGULATION 30
FIGURE 5 DATA TRIANGULATION METHODOLOGY 30
2.4 RESEARCH ASSUMPTIONS 31
2.5 RESEARCH LIMITATIONS 31

3 EXECUTIVE SUMMARY 32
FIGURE 6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION) 32
FIGURE 7 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY TECHNOLOGY, 2020 VS. 2025 33
FIGURE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 34
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE RADIATION THERAPY MARKET 35
?

4 PREMIUM INSIGHTS 36
4.1 INTRAOPERATIVE RADIATION THERAPY MARKET OVERVIEW 36
FIGURE 10 GROWING PREVALENCE OF CANCER IS DRIVING THE GROWTH OF THE INTRAOPERATIVE RADIATION THERAPY MARKET 36
4.2 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 37
FIGURE 11 IORT PRODUCTS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 37
4.3 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 37
FIGURE 12 SYSTEMS & ACCELERATORS SEGMENT WILL CONTINUE TO DOMINATE THE NORTH AMERICAN MARKET IN 2025 37
4.4 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 38
FIGURE 13 ELECTRON IORT SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE APAC INTRAOPERATIVE RADIATION THERAPY MARKET 38
4.5 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION & COUNTRY (2019) 39
FIGURE 14 BREAST CANCER SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN INTRAOPERATIVE RADIATION THERAPY MARKET IN 2019 39
4.6 INTRAOPERATIVE RADIATION THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40
FIGURE 15 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 40

5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
FIGURE 16 INTRAOPERATIVE RADIATION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
5.2.1 DRIVERS 42
5.2.1.1 Growing global prevalence of cancer 42
5.2.1.2 Improving reimbursement scenario 42
TABLE 1 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2019 42
5.2.1.3 Procedural advantages over EBRT 43
5.2.1.4 Technological advancements 43
5.2.2 RESTRAINTS 44
5.2.2.1 Dearth of trained personnel 44
5.2.2.2 Strong market positioning of alternative therapies 44
TABLE 2 ALTERNATIVES TO IORT PROCEDURES 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Emerging economies offer high growth potential 45
5.2.3.2 Growing applications of IORT 45
5.2.4 CHALLENGES 46
5.2.4.1 Risk of radiation exposure 46
5.3 IMPACT OF COVID-19 ON THE INTRAOPERATIVE RADIATION THERAPY MARKET 46
5.4 GLOBAL REGULATORY SCENARIO 48
5.4.1 NORTH AMERICA 48
5.4.1.1 US 48
TABLE 3 US: MEDICAL DEVICE CLASSIFICATION 49
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 49
5.4.1.2 Canada 50
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
FIGURE 17 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 51
5.4.2 EUROPE 52
FIGURE 18 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 53
5.4.3 ASIA PACIFIC 54
5.4.3.1 Japan 54
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 54
5.4.3.2 China 55
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 55
5.4.3.3 India 56
5.5 VALUE CHAIN ANALYSIS: GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET 57
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE 57
5.6 ECOSYSTEM COVERAGE: GLOBAL RADIOTHERAPY MARKET 58

6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE 59
6.1 INTRODUCTION 60
TABLE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 60
6.2 IORT PRODUCTS 60
TABLE 9 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 61
TABLE 10 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION) 61
6.2.1 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY 62
TABLE 11 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 62
6.2.2 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION 62
TABLE 12 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 62
6.2.3 SYSTEMS & ACCELERATORS 63
6.2.3.1 Affordability of systems & accelerators is supporting their adoption 63
TABLE 13 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY REGION, 2018–2025 (USD MILLION) 63
6.2.3.2 Intraoperative radiation therapy market for systems & accelerators, by technology 64
TABLE 14 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY TECHNOLOGY, 2018–2025 (USD MILLION) 64
6.2.3.3 Intraoperative radiation therapy market for systems & accelerators, by application 64
TABLE 15 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY APPLICATION, 2018–2025 (USD MILLION) 64
6.2.4 APPLICATORS & AFTERLOADERS 65
6.2.4.1 Growing approvals of applicators & afterloaders for the treatment of different cancer types is supporting the growth of this segment 65
TABLE 16 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY REGION, 2018–2025 (USD MILLION) 65
6.2.4.2 Intraoperative radiation therapy market for applicators & afterloaders, by technology 66
TABLE 17 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY TECHNOLOGY, 2018–2025 (USD MILLION) 66
6.2.4.3 Intraoperative radiation therapy market for applicators & afterloaders, by application 66
TABLE 18 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY APPLICATION, 2018–2025 (USD MILLION) 66
6.2.5 TREATMENT PLANNING SYSTEMS 67
6.2.5.1 Technological advancements & growing regulatory approvals are supporting market growth 67
TABLE 19 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY REGION, 2018–2025 (USD MILLION) 67
6.2.5.2 Intraoperative radiation therapy market for treatment planning systems, by technology 68
TABLE 20 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY TECHNOLOGY, 2018–2025 (USD MILLION) 68
6.2.5.3 Intraoperative radiation therapy market for treatment planning systems, by application 68
TABLE 21 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION) 68
6.2.6 ACCESSORIES 69
6.2.6.1 Growing number of IORT procedures to drive the adoption of IORT accessories 69
TABLE 22 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES,
BY REGION, 2018–2025 (USD MILLION) 69
6.2.6.2 Intraoperative radiation therapy market for accessories,
by technology 70
TABLE 23 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 70
6.2.6.3 Intraoperative radiation therapy market for accessories,
by application 70
TABLE 24 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES,
BY APPLICATION, 2018–2025 (USD MILLION) 70
6.3 IORT SERVICES 71
6.3.1 NEED FOR FREQUENT SOFTWARE UPGRADES TO DRIVE MARKET GROWTH 71
TABLE 25 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY REGION, 2018–2025 (USD MILLION) 71
6.3.2 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY TECHNOLOGY 71
TABLE 26 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 71
6.3.3 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY APPLICATION 72
TABLE 27 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY APPLICATION, 2018–2025 (USD MILLION) 72
7 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY 73
7.1 INTRODUCTION 74
TABLE 28 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 74
7.2 ELECTRON IORT 74
7.2.1 MINIMAL TREATMENT TIME OF THIS PROCEDURE HAS INCREASED ITS ADOPTION IN THE MARKET 74
TABLE 29 PROMISING CLINICAL TRIALS FOR ELECTRON IORT 74
TABLE 30 ELECTRON IORT MARKET, BY REGION, 2018–2025 (USD MILLION) 75
7.3 INTRAOPERATIVE BRACHYTHERAPY 75
7.3.1 LOWER COST THAN IOERT & BETTER DOSIMETRIC DISTRIBUTION ARE THE KEY FACTORS SUPPORTING MARKET GROWTH 75
TABLE 31 INTRAOPERATIVE BRACHYTHERAPY MARKET, BY REGION,
2018–2025 (USD MILLION) 76

8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION 77
8.1 INTRODUCTION 78
TABLE 32 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 78
8.2 BREAST CANCER 78
8.2.1 GROWING NUMBER OF BREAST CANCER CASES ACROSS THE GLOBE IS FUELING THE ADOPTION OF IORT 78
TABLE 33 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BREAST CANCER,
BY REGION, 2018–2025 (USD MILLION) 79
8.3 BRAIN TUMOR 79
8.3.1 GROWING NUMBER OF BRAIN TUMOR CASES TO DRIVE MARKET GROWTH 79
TABLE 34 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BRAIN TUMOR,
BY REGION, 2018–2025 (USD MILLION) 80
8.4 GASTROINTESTINAL CANCER 80
8.4.1 IORT OFFERS A SUITABLE ALTERNATIVE FOR GASTROINTESTINAL CANCER TREATMENT AS OPPOSED TO SURGERY OR CONVENTIONAL RADIATION 80
TABLE 35 INTRAOPERATIVE RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2018–2025 (USD MILLION) 81
8.5 HEAD & NECK CANCER 81
8.5.1 IORT IS HIGHLY EFFICIENT IN THE TREATMENT OF HEAD & NECK CANCER AS IT OFFERS BETTER TUMOR CONTROL 81
TABLE 36 INTRAOPERATIVE RADIATION THERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2018–2025 (USD MILLION) 82
?
8.6 COLORECTAL CANCER 82
8.6.1 IORT IS PROVEN EFFECTIVE FOR ADVANCED LOCAL AND RECURRENT COLORECTAL CANCER TREATMENT IN COMBINATION WITH PREOPERATIVE EBRT 82
TABLE 37 INTRAOPERATIVE RADIATION THERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2018–2025 (USD MILLION) 83
8.7 ENDOMETRIAL & CERVICAL CANCER 83
8.7.1 IORT IN COMBINATION WITH RADICAL RESECTION PROCEDURES IS A CURATIVE OPTION FOR PATIENTS WITH RECURRENT ENDOMETRIAL CANCER 83
TABLE 38 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ENDOMETRIAL & CERVICAL CANCER, BY REGION, 2018–2025 (USD MILLION) 83
8.8 LUNG CANCER 84
8.8.1 ALTERNATIVE TREATMENT OPTIONS FOR LUNG CANCER IS EXPECTED TO HAMPER THE GROWTH OF THIS SEGMENT 84
TABLE 39 INTRAOPERATIVE RADIATION THERAPY MARKET FOR LUNG CANCER,
BY REGION, 2018–2025 (USD MILLION) 84
8.9 OTHER CANCERS 84
TABLE 40 INTRAOPERATIVE RADIATION THERAPY MARKET FOR OTHER CANCERS,
BY REGION, 2018–2025 (USD MILLION) 85

9 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION 86
9.1 INTRODUCTION 87
TABLE 41 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION,
2018–2025 (USD MILLION) 87
9.2 NORTH AMERICA 87
FIGURE 20 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT 88
TABLE 42 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 89
TABLE 43 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 89
TABLE 44 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 89
TABLE 45 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 90
9.2.1 US 90
9.2.1.1 Higher adoption rate of innovative technologies to support market growth in the US 90
TABLE 46 US: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 91
9.2.2 CANADA 91
9.2.2.1 Surge in the incidence of cancer and favorable government guidelines to support the market growth 91
TABLE 47 CANADA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 92
9.3 EUROPE 92
TABLE 48 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 49 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 93
TABLE 50 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 94
TABLE 51 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 94
9.3.1 GERMANY 94
9.3.1.1 Growing awareness about advanced cancer treatment is expected to fuel the adoption of IORT products in Germany 94
TABLE 52 GERMANY: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 95
9.3.2 UK 95
9.3.2.1 Initiatives by public & private organizations to increase awareness about IORT 95
TABLE 53 UK: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 96
9.3.3 FRANCE 96
9.3.3.1 Preference for conventional radiotherapy is restraining the growth of the IORT market in France 96
TABLE 54 FRANCE: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 97
9.3.4 SPAIN 97
9.3.4.1 Growing geriatric population to support market growth 97
TABLE 55 SPAIN: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 98
9.3.5 ITALY 98
9.3.5.1 Rising awareness activities to support market growth 98
TABLE 56 ITALY: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 99
9.3.6 REST OF EUROPE 99
TABLE 57 REST OF EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 100
9.4 ASIA PACIFIC 100
FIGURE 21 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT 101
TABLE 58 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 102
TABLE 59 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 102
TABLE 60 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 103
TABLE 61 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 103
9.4.1 CHINA 104
9.4.1.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth 104
TABLE 62 CHINA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 104
9.4.2 JAPAN 105
9.4.2.1 Presence of universal healthcare reimbursement scenario and rising breast cancer cases?key factors driving market growth 105
TABLE 63 JAPAN: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 105
9.4.3 INDIA 105
9.4.3.1 Government initiatives to improve cancer treatment to drive market growth in India 105
TABLE 64 INDIA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 106
9.4.4 SOUTH KOREA 106
9.4.4.1 Rising R&D and promising clinical trials in the country to positively impact market growth 106
TABLE 65 SOUTH KOREA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 107
9.4.5 AUSTRALIA 107
9.4.5.1 Rising research investments and awareness campaigns are the key factors supporting market growth 107
TABLE 66 AUSTRALIA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 108
9.4.6 REST OF ASIA PACIFIC 108
TABLE 67 REST OF ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 108
9.5 LATIN AMERICA 109
TABLE 68 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 69 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 109
TABLE 70 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 110
TABLE 71 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 110
9.5.1 BRAZIL 111
9.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities 111
TABLE 72 BRAZIL: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 111
9.5.2 MEXICO 111
9.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico 111
TABLE 73 MEXICO: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 112
9.5.3 REST OF LATIN AMERICA 112
TABLE 74 REST OF LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 113
9.6 MIDDLE EAST & AFRICA 113
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA 113
TABLE 75 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 114
TABLE 76 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 114
TABLE 77 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 115

10 COMPETITIVE LANDSCAPE 116
10.1 OVERVIEW 116
FIGURE 22 KEY DEVELOPMENTS IN THE INTRAOPERATIVE RADIATION THERAPY MARKET FROM 2017 TO 2020 117
10.2 MARKET SHARE ANALYSIS 118
FIGURE 23 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2019 118
10.3 KEY MARKET DEVELOPMENTS 119
10.3.1 PRODUCT LAUNCHES & APPROVALS 119
10.3.2 ACQUISITIONS 119
10.3.3 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 120
10.3.4 EXPANSIONS 120

11 COMPANY EVOLUTION MATRIX AND COMPANY PROFILES 121
11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY 121
11.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019) 121
11.1.2 STARS 121
11.1.3 EMERGING LEADERS 121
11.1.4 EMERGING COMPANIES 122
11.1.5 PERVASIVE 122
FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: OVERALL MARKET (2019) 122
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING: EMERGING PLAYERS (2019) 123
11.2 COMPANY PROFILES 124
(Business overview, Products offered, Recent developments, MNM view)*
11.2.1 ZEISS GROUP 124
FIGURE 26 ZEISS GROUP: COMPANY SNAPSHOT (2019) 124
11.2.2 ICAD, INC. 126
FIGURE 27 ICAD, INC.: COMPANY SNAPSHOT (2019) 126
11.2.3 ECKERT & ZIEGLER 128
FIGURE 28 ECKERT & ZIEGLER: COMPANY SNAPSHOT (2019) 128
11.2.4 ARIANE MEDICAL SYSTEMS LTD. 131
11.2.5 BECTON, DICKINSON AND COMPANY 132
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 132
11.2.6 ELEKTA AB 134
FIGURE 30 ELEKTA AB: COMPANY SNAPSHOT (2019) 134
11.2.7 GMV INNOVATING SOLUTIONS 136
11.2.8 INTRAOP MEDICAL, INC. 137
11.2.9 ISOAID, LLC 138
11.2.10 ISORAY, INC. 139
FIGURE 31 ISORAY, INC.: COMPANY SNAPSHOT (2019) 139
11.2.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD. 141
11.2.12 SEEDOS LTD. 142
11.2.13 SENSUS HEALTHCARE, INC. 143
FIGURE 32 SENSUS HEALTHCARE, INC.: COMPANY SNAPSHOT (2019) 143
11.2.14 S.I.T. SORDINA IORT TECHNOLOGIES S.P.A. 145
11.2.15 VARIAN MEDICAL SYSTEMS, INC. 146
FIGURE 33 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2019) 146
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11.2.16 OTHER COMPANIES 149
11.2.16.1 Salutaris Medical Devices 149
11.2.16.2 Brainlab AG 149
11.2.16.3 RaySearch Laboratories 150
11.2.16.4 REMEDI Co., Ltd. 150
11.2.16.5 Merit Medical Systems 151

12 APPENDIX 152
12.1 DISCUSSION GUIDE 152
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 156
12.3 AVAILABLE CUSTOMIZATIONS 158
12.4 RELATED REPORTS 158
12.5 AUTHOR DETAILS 159